Johnson & Johnson said on Thursday it will discontinue a late-stage study of an experimental E.coli vaccine it was developing in partnership with Sanofi.
The drugmaker said its decision was based on the recommendation of an independent committee that found the vaccine candidate may not be sufficiently effective compared with a placebo in preventing infections caused by a group of bacteria commonly found in the gut.
No safety signals related to the experimental vaccine were identified, J&J said, adding that it was conducting follow-ups for participants currently enrolled in the trial.
The study was testing the safety and efficacy of a single dose of the experimental shot, ExPEC9V, in preventing E.coli disease, including sepsis and blood infections.
A peace agreement between Washington and Tehran is yet to materialise, with U.S. President Donald Trump saying that negotiations are incomplete and a...
Iran’s Islamic Revolutionary Guard Corps (IRGC) said on Monday it had authorised 32 vessels to pass through the Strait of Hormuz, as Tehran and Wash...
Azerbaijan Railways (ADY) resumed passenger services between Baku and Tbilisi on 25 May, with the first train departing Baku Railway Station at 23:10...
Doctors working on the front lines of the Ebola outbreak in the Democratic Republic of Congo say attacks on treatment centres and fleeing patients are...
Russia has warned foreign nationals to leave Kyiv, saying it has launched a new wave of strikes targeting Ukraine’s defence industry and military co...
The inaugural Enhanced Games began in Las Vegas on Sunday (24 May), launching one of the most controversial experiments in modern sport, in which athletes openly compete using performance-enhancing drugs banned under traditional anti-doping rules.
A peace agreement between Washington and Tehran is yet to materialise, with U.S. President Donald Trump saying that negotiations are incomplete and an Iranian Foreign Ministry Spokesman saying that a deal isn't imminent.
A "largely negotiated" memorandum of understanding on an Iran peace deal would reopen the Strait of Hormuz, U.S. President Donald Trump said on Saturday, though the Iranian Fars news agency disputed that claim.
The World Health Organization warned on Monday that the fast-moving Ebola outbreak in the Democratic Republic of the Congo and Uganda was outpacing response efforts, with 220 suspected deaths reported so far.
Start your day informed with the AnewZ Morning Brief. Here are the top stories for 25th May, covering the latest developments you need to know.
The World Health Organisation has warned that the risk of a widening Ebola outbreak in the Democratic Republic of the Congo (DRC) has escalated to “very high” at national level.
A luxury polar expedition vessel linked to a hantavirus outbreak has arrived in Rotterdam, where health authorities have placed the final 27 people on board into quarantine and have begun containment measures.
Medical teams are being rushed to eastern Democratic Republic of Congo (DRC) following a fast-moving Ebola outbreak that has already caused dozens of suspected deaths and raised fears of wider regional spread.
The World Health Organisation’s designation of the Bundibugyo Ebola virus outbreak as a Public Health Emergency of International Concern (PHEIC) is a stark reminder that Ebola remains a persistent global health threat rather than a disease of the past.
The risk from hantavirus to the general public remains very low, and the U.S. Centres for Disease Control and Prevention (CDC) has more than 100 staff members actively working on the outbreak, a governmental health official said on Wednesday.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment